Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 47 626.0 |
96 | EP file number | EAKZ | 11 16 5204.6 |
97 | EP publication number | EPN | 2353611 |
54 | Designation/title | TI | Arzneimittelkonjugate und deren Verwendung zur Behandlung von Krebs, einer Autoimmunerkrankung oder einer Infektionskrankheit |
51 | IPC main class | ICM (ICMV) | A61K 47/50 (2017.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01), C07K 5/02 (2006.01), C07K 16/46 (2006.01), C07K 16/30 (2006.01), C07K 16/12 (2006.01) |
22 | DE application date | DAT | Jul 31, 2003 |
96 | EP application date | EAT | Jul 31, 2003 |
43 | Date of first publication | OT | Aug 10, 2011 |
| Date of publication of grant | PET | May 13, 2015 |
71/73 | Applicant/owner | INH | Seagen Inc. (n.d.Ges.d. Staates Delaware), Bothell, WA, US |
72 | Inventor | IN | Senter, Peter D., Bothell, WA 98021, US; Doronina, Svetlana, Bothell, WA 98021, US; Toki, Brian E., Bothell, WA 98021, US |
74 | Representative | VTR | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
| Address for service | | Kraus & Weisert Patentanwälte PartGmbB, 80539 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 400403 P Jul 31, 2002
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002353611 Searchable text:
EP000002353611 Original document:
EP000002353611B1 Searchable text:
EP000002353611B1 |
43 | Date of first publication | EVT | Aug 10, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Sep 24, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 2, 2023 (Show all update days)(Hide all update days)- Sep 24, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jun 4, 2021 |
| Issue number | HN | 28 |
| Year | PJ | 2021 |
| Publication date | VT | Jul 15, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Seagen Inc. (n.d.Ges.d. Staates Delaware), Bothell, WA, US |
71/73 | Previous applicant/owner | INHF | Seattle Genetics, Inc., Bothell, Wash., US |
| Date of update of the procedure | REGT | Jul 15, 2021 |